Hemerion Therapeutics

Operator of a biotechnology platform intended to treat resistant tumors using proprietary photosensitizing molecules paired with advanced laser light technologies. The company offers a unique combinat...

Healthcare
Villeneuve-d'Ascq, France
Founded 2020
15 employees
Website
Valuation
$0
Share Price
N/A
Total Raised
$14.2M
Last Round
N/A

Get the full picture

Create a free account to unlock Hemerion Therapeutics's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required